Phase III trials - Health Technology Insights

Merz Begins Phase III Trials of XEOMIN for Migraine Prevention

August 25, 2025

Trials designed to reflect migraine burden and patient experience Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced that the first patients

BREZTRI met primary endpoints in KALOS and LOGOS Phase III trials in asthma

May 2, 2025

Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose triple-combination therapy BREZTRI AEROSPHERE met

Categories

Tag: Phase III trials

Merz Begins Phase III Trials of XEOMIN for Migraine Prevention

BREZTRI met primary endpoints in KALOS and LOGOS Phase III trials in asthma

Share With

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 25 August 2025

ShiftMed, TELUS Partner on Health Workforce Solutions

BoldAge PACE Adds Brian Clem to Board of Directors

Core Spaces Gives Free Mental Health Support to Residents

How AI Is Reshaping Real-World Healthcare Delivery

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands